Evidence map›Paper›PMID 33547522›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

A high leukocyte count and administration of hydrocortisone hamper PCR-based diagnostics for bloodstream infections.

Silke Huber, Johannes Weinberger, Matthias Pilecky, Ingo Lorenz, Anita Schildberger, Viktoria Weber, Stefan Fuchs, Wilfried Posch, Ludwig Knabl, Reinhard Würzner and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Silke HuberInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Johannes WeinbergerAres Genetics GmbH, Karl-Farkas-Gasse 18, 1030, Vienna, Austria.
Matthias PileckyCenter for Biomedical Technology, Department for Biomedical Research, Danube University Krems, Krems, Austria.
Ingo LorenzDepartment of General and Surgical Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Anita SchildbergerCenter for Biomedical Technology, Department for Biomedical Research, Danube University Krems, Krems, Austria.
Viktoria WeberCenter for Biomedical Technology, Department for Biomedical Research, Danube University Krems, Krems, Austria.
Stefan FuchsInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Wilfried PoschInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Ludwig KnablInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Reinhard WürznerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria.
Andreas E Posch *Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030, Vienna, Austria. andreas.posch@ares-genetics.com.
Dorothea Orth-Höller *Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstrasse 41, 6020, Innsbruck, Austria. do@mb-lab.com.ORCID http://orcid.org/0000-0003-2904-5192
Innsbruck Medical University · ATUniversität für Weiterbildung Krems · ATBiocrates Life Sciences (Austria) · AT

Funding

Österreichische Forschungsförderungsgesellschaft 871243
6 · The paper itself

Abstract

Bloodstream infections (BSIs) require an accurate and fast identification of causative pathogens. Molecular diagnostics, in particular polymerase chain reaction (PCR)-based approaches for BSI diagnostics directly from whole blood, suffer from limitations such as inhibition leading to invalid results. In this retrospective study, we analyzed 23 parameters for their potential interference with LightCycler SeptiFast PCR tests (n = 2167) routinely performed at our institution. The overall inhibition rate was 9.1%. Test date, type of ward, procalcitonin levels, high leukocyte counts, and absolute neutrophil count were significantly associated with inhibition. For a subset (n = 448), cut-off values for leukocyte counts of < 5700 cells/μL and ≥ 26,900 cells/μL were significantly associated with a low (5%) and high (67%) inhibition risk. For patients with a moderate to high leukocyte count (5700-26,900 cells/μL), the additional administration of hydrocortisone significantly increased the inhibition risk. Furthermore, freezing of blood samples prior to DNA extraction and SF testing appeared to neutralize inhibitory factors. It remains to be investigated whether other molecular diagnostic tests are susceptible to similar inhibiting parameters.

Indexed as

AdolescentAdultAgedBlood CultureChildChild, PreschoolFemaleHumansHydrocortisoneInfantInfant, NewbornLeukocyte CountMaleMiddle AgedMolecular Diagnostic TechniquesMultiplex Polymerase Chain ReactionHydrocortisoneBloodstream infectionInhibitionLeukocytosisMolecular diagnosticsMultiplex PCRSepsis

Identifiers

PMID33547522
OpenAlexW3129122849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.